222-G Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (

Ítems similars

• Mechanism and Clinical Application of PD-1/PD-L1 Inhibitors in Immunotherapy
  per: Yang Xicheng
  Publicat: (2022-01-01)
• Spotlight on nuclear PD-L1 in ovarian cancer chemoresistance: hidden but mighty
  per: Meshach Asare-Werehene, et al.
  Publicat: (2025-07-01)
• Predicting ovarian cancer prognosis and immunotherapy response through siglec15 and PD-L1 expression analysis
  per: Aiyue Zhao, et al.
  Publicat: (2025-12-01)
• Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway
  per: Thamiris Becker Scheffel, et al.
  Publicat: (2021-02-01)
• Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
  per: Huiyu Yan, et al.
  Publicat: (2023-10-01)